Stock Events

Stock Events

Janus Living

$29.12

127

+$0.13+0.45% Thursday 20:00

+$0.00+0%Thursday 22:30After hours

Statistics

Day High

29.15

Day Low

29.11

52W High

29.61

52W Low

22.76

Volume

44,998

Avg. Volume

-

Mkt Cap

6.18B

P/E Ratio

-

Dividend Yield

-

Dividend

-

Upcoming

Dividends

0%Dividend Yield

Apr 22

$0.06

Jan 22

$0.46

Oct 21

$0.35

Jul 21

$0.35

Apr 21

$0.17

10Y Growth

N/A

5Y Growth

N/A

3Y Growth

N/A

1Y Growth

N/A

Earnings

6AugExpected

Q4 0

Q1 2025

Q2 2025

Q4 2025

Q1 2026

Next

-0.36

-0.29

-0.21

-0.14

Expected EPS

-0.15

Actual EPS

N/A

Financials

-Profit Margin

Unprofitable

2018

2019

2020

2021

2022

2023

0Revenue

-7.81MNet Income

Analyst Ratings

29.18Average Price Target

The highest estimate is 34.00.
From 11 ratings within the last 6 months. This is not an investment recommendation.

Buy

91%

Hold

9%

Sell

0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow JAN. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Pfizer is a global pharmaceutical company that competes with JanOne in the development of treatments for various diseases, including those JanOne targets with its non-opioid pain management solutions.

Johnson & Johnson

Johnson & Johnson, through its pharmaceutical segment, competes in developing medications and treatments that can overlap with JanOne's focus areas, including pain management.

AbbVie operates in the pharmaceuticals sector, focusing on innovative therapies, directly competing with JanOne in areas like chronic pain treatment.

Merck is involved in the development and manufacturing of drugs that address serious health issues, competing with JanOne in the pharmaceutical space, especially in pain management solutions.

Teva- Pharmaceutical Industries

Teva Pharmaceutical Industries specializes in generic and specialty medicines, including pain management, making it a competitor to JanOne in the non-opioid pain relief market.

Novartis is a global healthcare company that produces drugs in various therapeutic areas, including pain, competing with JanOne's mission to offer alternative pain solutions.

Bristol-Myers Squibb

Bristol Myers Squibb is a biopharmaceutical company that develops medicines in several therapeutic areas, potentially competing with JanOne in the area of pain management.

Eli Lilly and Company focuses on pharmaceuticals in areas that could compete with JanOne, especially considering their work on pain and chronic conditions.

GlaxoSmithKline is a healthcare company that produces pharmaceuticals across various areas, including pain relief, making it a competitor to JanOne.

Sanofi is a global life sciences company that offers a broad range of medicines, including those for pain management, competing with JanOne's focus on non-opioid solutions.

Holdings

Regions

Sectors

About

Janus Living, Inc. functions as a specialized real estate investment trust (REIT), concentrating solely on the senior housing sector. Its portfolio encompasses numerous communities situated throughout the United States, each meticulously crafted to provide residents with thoughtfully designed, amenity-rich living spaces. The company was established in December 2025 and operates its main office from Denver, Colorado.

Show more...

CEO

Mr. Scott M. Brinker

Employees

5

Country

United States

ISIN

US4710241096

Listings

0 Comments

Share your thoughts

FAQ

What is Janus Living stock price today?▼

The current price of JAN is $29.12 USD — it has increased by +0.45% in the past 24 hours. Watch Janus Living stock price performance more closely on the chart.

What is Janus Living stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Janus Living stocks are traded under the ticker JAN.

What is Janus Living market cap?▼

Today Janus Living has the market capitalization of 6.18B

When is the next Janus Living earnings date?▼

Janus Living is going to release the next earnings report on August 06, 2026.

What is Janus Living revenue for the last year?▼

Janus Living revenue for the last year amounts to 0 USD.

What is Janus Living net income for the last year?▼

JAN net income for the last year is -7.81M USD.

Does Janus Living pay dividends?▼

Yes, JAN dividends are paid quarterly. The last dividend per share was 0.16 USD. As of today, Dividend Yield (FWD)% is 0%.

How many employees does Janus Living have?▼

As of July 06, 2026, the company has 5 employees.

In which sector is Janus Living located?▼

Janus Living operates in the Other sector.

When did Janus Living complete a stock split?▼

The last stock split for Janus Living was on April 22, 2019 with a ratio of 1:5.

Where is Janus Living headquartered?▼

Janus Living is headquartered in Denver, United States.